Imugene Ltd.
Imugene Ltd. is a clinical‑stage immuno‑oncology biotech developing CAR‑T therapies (azer‑cel, CF33 CD19), oncolytic virotherapy (CF33 VAXINIA), and cancer vaccines (HER‑VAXX, PD1‑Vaxx) in phase 1‑2 trials, headquartered in Sydney.
Headquarters: Australia (AUS)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- HQ: Sydney
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.